
    
      Randomized, double-blind, placebo-controlled trial with octenisept速 or placebo in patients
      with chronic leg ulcers. The study will be conducted at a single center with a total of 70
      patients. Patients will be randomized to either the octenisept速 group or to the placebo
      group.

      Primary Objectives: Antimicrobial efficacy of octenisept速 compared to placebo. Secondary
      Objectives: Subjective tolerance of octenisept速, evaluation of wound parameters.
    
  